Automated Cell Culture System with Machine Learning Quality Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biological manufacturing processes, particularly those involving mammalian cells, face significant variability and inefficiency due to the stochastic nature of cell processes, leading to low yields, high labor costs, and scalability issues.

Innovation Solution

The development of automated cell culture systems that integrate advanced imaging techniques, machine learning for objective quality assessment, and modular, closed-environment cell culture systems to enhance efficiency, scalability, and consistency in biological manufacturing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual cell culture processes are used with human operators making observations and edits, then cell quality can be monitored and adjusted, but the process becomes expensive, unscalable, and prone to high variability

Engineering Contradiction:
Improvecell quality controlVSAvoidscalability
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent replaces manual mechanical manipulation of cells and colonies with automated robotic systems. The robotic arm performs selective transfer, removal, and manipulation of cell colonies based on image analysis, eliminating human hands-on operations while maintaining control over cell quality and enabling scalability to large production volumes

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system implements automated image capture, analysis, and decision-making algorithms that enable the cell culture process to self-monitor and self-adjust. The machine learning models automatically identify quality deviations and trigger appropriate actions without human intervention, creating a self-regulating system that maintains reliability while scaling

Inventive Principle:
Principle #25Self-service

2Reliability

If frequent transfer between cell culture containers is performed to manage cell density, then cell overgrowth is prevented, but the process becomes labor intensive and increases contamination risk

Engineering Contradiction:
Improvecontamination controlVSAvoidprocess simplicity
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent implements continuous automated monitoring through time-lapse imaging and continuous environmental control within closed containers. This allows the system to maintain optimal cell culture conditions and manage cell density through automated interventions without breaking the sterile barrier, eliminating the need for repeated manual transfers while preventing contamination

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The system introduces automated robotic arms and closed-container interfaces as intermediaries between the operator and the cell culture. These intermediaries enable all operations to occur within sealed environments, preventing direct human contact with cells and eliminating contamination risks associated with manual transfers

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If large bioreactors are used for bulk cell production, then large volumes of cells can be produced, but the process lacks feedback control to account for variability

Engineering Contradiction:
Improvecell production volumeVSAvoidprocess consistency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements real-time feedback control through continuous image capture and machine learning analysis. The system monitors cell morphology, density, and health parameters throughout the culture process and automatically adjusts cultivation conditions or triggers selective removal of poor-quality colonies, ensuring consistent product quality even at large production scales

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system divides the cell culture into individually monitorable and controllable units (colonies or cell groups) within the bioreactor. This segmentation allows selective intervention on specific cell populations while maintaining bulk production, enabling feedback control at the colony level while achieving large-scale output

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20250075189A1Platforms and systems for automated cell culture
Publication Date: 2025.03.06 CELLINO BIOTECH INC
  • US20250075189A1 patent drawing
  • US20250075189A1 patent drawing
  • US20250075189A1 patent drawing

AI summary

Disclosed herein are platforms, systems, and methods including a cell culture system that includes a cell culture container comprising a cell culture, the cell culture receiving input cells, a cell imaging subsystem configured to acquire images of the cell culture, a computing subsystem configured to perform a cell culture process on the cell culture according to the images acquired by the cell imaging subsystem, and a cell editing subsystem configured to edit the cell culture to produce output cell products according to the cell culture process.